PACS Group Inc(PACS) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | 25.6 | EPS (ttm) | 1.67 | Insider Own | 71.56% | Shs Outstand | 158.3M | Perf Week | -4.22% |
| Market Cap | 6.76B | Forward P/E | 16.31 | EPS next Y | 10.63% | Insider Trans | -1.53% | Shs Float | 45.0M | Perf Month | -3.61% |
| Enterprise Value | 10.00B | PEG | 1.05 | EPS next Q | 0.57 | Inst Own | 30.92% | Short Float | 7.39% | Perf Quarter | 19.03% |
| Income | 0.27B | P/S | 1.22 | EPS this Y | 28.42% | Inst Trans | 5.62% | Short Ratio | 3.88 | Perf Half Y | 19.66% |
| Sales | 5.55B | P/B | 6.09 | EPS next 5Y | 15.55% | ROA | 4.82% | Short Interest | 3.33M | Perf YTD | 11.28% |
| Book/sh | 7.01 | P/C | 38.23 | EPS past 3/5Y | -41.5% -10.97% | ROE | 28.08% | 52W High | -13.68% ($49.49) | Perf Year | 293.01% |
| Cash/sh | 1.12 | P/FCF | 14.84 | Sales past 3/5Y | 29.74% 45.92% | ROIC | 6.23% | 52W Low | 314.35% ($10.31) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | 20.87 | EPS Y/Y TTM | 101.51% | Gross Margin | 15.37% | Volatility(W/M) | 4.13% 3.69% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 1.8 | Sales Y/Y TTM | 15.15% | Oper. Margin | 7.41% | ATR (14) | 1.84 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.91 | EPS Q/Q | 53.08% | Profit Margin | 4.85% | RSI (14) | 43.88 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.91 | Sales Q/Q | 9.07% | SMA20 | -2.02% ($43.6) | Beta | -0.07 | Target Price | $59 |
| Payout | - | Debt/Eq | 3.07 | Earnings | 2026/8/4 | SMA50 | -4.43% ($44.7) | Rel Volume | 1.33 | Prev Close | $42.09 |
| Employees | 47455 | LT Debt/Eq | 2.89 | EPS/Sales Surpr. | 17.43% 1% | SMA200 | 11.26% ($38.4) | Avg Volume(3M) | 0.86M | Price | $42.72 |
| IPO | 2024/4/11 | Option/Short | Yes/Yes | Trades | 9403 | Volume | 1,141,213 | Change | 1.5% |
Company
PACS is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
A U.S. healthcare facilities company that operates skilled nursing facilities and post-acute care facilities. It provides skilled nursing and assisted living care for patients who require post-acute recovery and rehabilitation, and has rapidly expanded its facility footprint through acquisitions. This healthcare facilities stock has earnings tied to occupancy rates, government insurance reimbursement rates, and acquisition integration.
Over the past 1 year, on the higher side
14% below its 1-year high.
PACS has weak earning power
7.41% of revenue is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +28.4% this year.
Tap to view numbers
The price looks about right
Trading at 25.6 times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 3 quarters.
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have paid off
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 30.9%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
FFTY 0.03%
XHS 0.02%
TAX 0.01%
IVSS 0.01%
PIPE 0.01%It ranks #4 in the industry
Based on market cap of $7B.
PACS $7B PER 25.6
HCA $93B PER 14.4
THC $21B PER 10.3
DVA $12B PER 16.4
FAQ
What kind of company is PACS?
PACS belongs to the Healthcare sector and operates in the Medical Care Facilities industry.
What is the market cap of PACS?
The market cap of PACS is approximately $6.8B, ranking 1,155 within its sector.
What is the P/E ratio of PACS?
PACS has a P/E ratio of approximately 25.6x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for PACS?
PACS has recorded a 52-week high of $49.49 and a low of $10.31.
